Literature DB >> 15836574

Neuroleptics in headache.

Hua C Siow1, William B Young, Stephen D Silberstein.   

Abstract

OBJECTIVES: To review the mechanism of action of neuroleptics, the evidence for their efficacy, and their clinical use in headache treatment.
BACKGROUND: Neuroleptics and antiemetics have long been used for headache treatment; however, they have not been widely utilized because of general unfamiliarity with them and concerns about their adverse events. With the recent advent of the atypical neuroleptics and their improved adverse event profile, our armamentarium for headache treatment has expanded. In this review, we explore the mechanism of action of these classes of drugs, their adverse events, and the evidence for their efficacy. We also detail our experience with the different drugs and how we use them as both acute and preventive headache therapy.
DESIGN: A review of published literature was obtained through a MEDLINE search on the use of neuroleptics in headache therapy.
CONCLUSION: Neuroleptics have widespread evidence supporting their use in headache treatment and present an important part of the armaterium against headache.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15836574     DOI: 10.1111/j.1526-4610.2005.05074.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  3 in total

1.  Use of dopamine antagonists in treatment of migraine.

Authors:  Michael J Marmura
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

2.  Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations.

Authors:  Spiridon Papapetropoulos; Carlos Singer
Journal:  Head Face Med       Date:  2006-12-07       Impact factor: 2.151

3.  Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study.

Authors:  Alfredo I Niño-Maldonado; Gary Caballero-García; Wilfrido Mercado-Bochero; Fernando Rico-Villademoros; Elena P Calandre
Journal:  Head Face Med       Date:  2009-11-08       Impact factor: 2.151

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.